Background Severe acute respiratory syndrome coronavirus 2 vaccination reduces
morbidity and mortality associated with coronavirus disease 2019 (COVID-19); …

Brugada syndrome (BrS) is a hereditary cardiac disease predisposing to sudden cardiac
death in patients with structurally normal heart. Fever has been reported not only to unmask …

The eponymous syndrome first described by the Brugada brothers in the early 1990s
consists of characteristic ST abnormalities and an increased risk of sudden cardiac death …

First described in the 1990s, the Brugada syndrome initially characterized unexplained
sudden cardiac death in healthy Southeast Asian men. 1 Mutations in the cardiac sodium …

A 43-year-old man presented with cardiac arrest 2 days after the second coronavirus
disease 2019 (COVID-19) vaccination with an mRNA vaccine. Electrocardiograms showed …

Background Fever is a potential side effect of the Covid‐19 vaccination. Patients with
Brugada syndrome (BrS) have an increased risk of life‐threatening arrhythmias when …

In 1992, Brugada syndrome (BS) was first described; an often unrecognized cardiac
conduction disorder mainly associated with unexplained sudden cardiac arrest and …

Brugada syndrome is a rare hereditary disorder characterized by distinct ECG findings,
complex genetics, and a high risk of sudden cardiac death. Recognition of the syndrome is …

Brugada syndrome (BrS) is an inheritable sudden cardiac death disease mainly caused by
SCN5A mutations. Traditional approaches can be costly and time-consuming if all candidate …

Abstract Background Brugada syndrome (BrS) is a rare genetic disease that causes sudden
cardiac death (SCD) and arrhythmia. SCN5A pathogenic variants (about 30% of diagnosed …